Cargando…
P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011767/ http://dx.doi.org/10.1097/01.HS9.0000829652.00958.65 |
_version_ | 1784687690722050048 |
---|---|
author | Iula, R Trastulli, F Della Pepa, R D’Ambrosio, A Romano, M Leone, A Gaeta, G Palmieri, S Rocco, S Pane, F Ferrara, F Catalano, L |
author_facet | Iula, R Trastulli, F Della Pepa, R D’Ambrosio, A Romano, M Leone, A Gaeta, G Palmieri, S Rocco, S Pane, F Ferrara, F Catalano, L |
author_sort | Iula, R |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9011767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-90117672022-04-18 P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA Iula, R Trastulli, F Della Pepa, R D’Ambrosio, A Romano, M Leone, A Gaeta, G Palmieri, S Rocco, S Pane, F Ferrara, F Catalano, L Hemasphere Poster Lippincott Williams & Wilkins 2022-04-05 /pmc/articles/PMC9011767/ http://dx.doi.org/10.1097/01.HS9.0000829652.00958.65 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Poster Iula, R Trastulli, F Della Pepa, R D’Ambrosio, A Romano, M Leone, A Gaeta, G Palmieri, S Rocco, S Pane, F Ferrara, F Catalano, L P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title | P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_full | P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_fullStr | P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_full_unstemmed | P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_short | P20: POLYCENTRIC “REAL LIFE” STUDY OF BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA |
title_sort | p20: polycentric “real life” study of belantamab mafodotin for relapsed/refractory multiple myeloma |
topic | Poster |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011767/ http://dx.doi.org/10.1097/01.HS9.0000829652.00958.65 |
work_keys_str_mv | AT iular p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT trastullif p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT dellapepar p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT dambrosioa p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT romanom p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT leonea p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT gaetag p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT palmieris p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT roccos p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT panef p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT ferraraf p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma AT catalanol p20polycentricreallifestudyofbelantamabmafodotinforrelapsedrefractorymultiplemyeloma |